News – Page 907 – Endpoints News

SIGN UP

Kite partner HiFiBiO closes $67M round for preclinical antibody candidates churned out of single-cell analytics ...

6 years ago

Alexion's cash cow receives label expansion; Matthew Dallas tapped to CFO post at Zealand Pharma

6 years ago

Bristol-Myers, AbbVie's multiple myeloma drug wins second EU nod as part of triple regimen

6 years ago

The Woodford effect: Teetering on the edge, his co-investors are feeling the pain — and they want it to stop

6 years ago

AstraZeneca wins a round in their PhIII COPD bout with GSK — but can they catch up?

6 years ago

Purdue Pharma proposes $12B settlement to clean up opioid mess — report

6 years ago

Decades in the making, Kyowa Hakko Kirin finally wins FDA approval for add-on Parkinson's therapy

6 years ago

Immatics scores $75M upfront in TCR deal with Celgene as interest in tech burgeons

6 years ago

Top FDA exec Edward Cox jumps ship and joins Regeneron as new regulatory VP

6 years ago

GSK workers may be in trouble with UK authorities; EU pledges €550M to fight AIDS, tuberculosis and malaria

6 years ago

Adaptimmune pledges $312M for Noile-Immune's T cell boosting tech in drive to deliver on TCR promise

6 years ago

Bristol-Myers opens up the Phase 0 pathway in testing its new cancer therapies, following in Celgene’s footsteps

6 years ago

GSK licenses Ionis' experimental hep B treatments in up to $262M deal

6 years ago

For sale: Boston Children’s team touts a new CRISPR delivery system for triple-negative breast cancer — plus — ...

6 years ago

Santhera's Duchenne effort gets a boost on positive PhIIa for alternative steroid vamorolone — though there's a lot ...

6 years ago

Franchise killer: Are Regeneron and Sanofi about to get handed their walking papers on PCSK9?

6 years ago

Cadre of gene-editing biotechs rally against altering DNA that could affect future generations

6 years ago

After inking a string of pipeline deals, Boehringer Ingelheim is doing a makeover of the top executive team

6 years ago

Oklahoma judge finds J&J guilty for its role in the opioid epidemic — but shares spike on $572M fine

6 years ago

ADC Therapeutics signs pact with Freenome; Shanghai Henlius Biotech eyes $600M for Hong Kong IPO

6 years ago

Out to shake up PCSK9 market, Medicines Co boasts of pivotal PhIII win for inclisiran

6 years ago

Lilly's Taltz wins third approval, this time in patients with active ankylosing spondylitis

6 years ago

FibroGen founder and CEO Thomas Neff dies unexpectedly as lead drug nears commercial threshold

6 years ago

FDA to roll out modernization plan in push for data interoperability

6 years ago

First page Previous page 904 905 906907908 909 910 Next page Last page